Eisai First Japan Member To Global TB-Research Partnership
This article was originally published in PharmAsia News
Executive Summary
Eisai said it has joined the international partnership to help discover new drugs for treating tuberculosis, still a global threat, joining major drug makers such as AstraZeneca, Eli Lilly and Sanofi.